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Abstract
Background: Low back pain (LBP) is one of the most common musculoskeletal disorders, causing significant
personal and social burden. Current research is focused on the processes of the central nervous system (particularly
the sensorimotor system) and body perception, with a view to developing new and more efficient ways to treat
chronic low back pain (CLBP). Several clinical tests have been suggested that might have the ability to detect
alterations in the sensorimotor system. These include back-photo assessment (BPA), two-point discrimination (TPD),
and the movement control tests (MCT).
The aim of this study was to determine whether the simple clinical tests of BPA, TPD or MCT are able to
discriminate between nonspecific CLBP subjects with altered body perception and healthy controls.
Methods: A cross-sectional study was conducted. At one point in time, 30 subjects with CLBP and 30 healthy
controls were investigated through using BPA, TPD and MCT on the lower back. Correlations among the main
covariates and odds ratios for group differences were calculated.
Results: MCT showed an odds ratio for the presence of CLBP of 1.92, with a statistically significant p-value (0.049)
and 95%CI. The TPD and BPA tests were unable to determine significant differences between the groups.
Conclusions: Of the three tests investigated, MCT was found to be the only suitable assessment to discriminate
between nonspecific CLBP subjects and healthy controls. The MCT can be recommended as a simple clinical tool to
detect alterations in the sensorimotor system of nonspecific CLBP subjects. This could facilitate the development of
tailored management strategies for this challenging LBP subgroup. However, further research is necessary to
elucidate the potential of all the tests to detect alterations in the sensorimotor system of CLBP subjects.
Trial registration: No trial registration was needed as the study contains no intervention. The study was approved
by the Swiss Ethics Commission of Northwest and Central Switzerland (EKNZ) reference number 2015–243.
Keywords: Chronic nonspecific low back pain, Back-photo assessment, Two-point discrimination, Movement
control test
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Background
Low Back Pain (LBP) is one of the most common mus-
culoskeletal disorders and causes significant personal
and social burden [1]. Currently, 85% of LBP cases are
classified as nonspecific LBP, meaning that there are no
specific structural causes that can solely explain the
symptoms [2]. Due to the complexity of the situation,
outcomes for unimodal treatments are poor [1]. Thus,
good strategies to manage nonspecific LBP, particularly
when a chronic pain state exists, include conservative
and invasive treatments. Nevertheless, because of the na-
ture of the nonspecific structural causes, a tailored man-
agement strategy for nonspecific chronic LBP treatment
remains a major challenge [3–5]. Chronic pain is defined
as pain lasting longer than 3months [6].
Recent neuroimaging studies have demonstrated
neurochemical, structural and functional alterations in
the primary sensory cortex in subjects with chronic low
back pain (CLBP) [2, 4, 5]. These findings support the
emerging evidence that the central nervous system
(CNS) processes also contribute to CLBP [7, 8]. CLBP
may increase sensitivity in the spinal cord and the cor-
tex, leading to the amplification of peripheral inputs.
Furthermore, the inhibitory mechanisms of the CNS
demonstrate reduced functionality in CLBP subjects [5,
7, 9, 10]. These factors may contribute to the sensori-
motor changes and altered body perceptions, as well as
to reduced grey matter volume in the somatosensory
cortex [5, 7, 9, 10]. Identifying such alterations through
neuroimaging assessments are costly and difficult to ac-
cess. Therefore, simple clinical tests to identify such al-
terations in the sensorimotor system are increasingly
important to physicians and physical therapists to facili-
tate the development of tailored management strategies
for patients in a chronic low back pain state, especially
for the challenging subgroup of the nonspecific CLBP
group. Further research on relevant simple clinical tools
is needed.
Several clinical assessments are thought to be capable
of detecting changes in the sensorimotor system and
body perception. It was decided to investigate three of
these common assessment tools in this paper due to
their practicability in clinical work. The aim of this repli-
cation study was to determine whether the simple clin-
ical tests are able to discriminate between nonspecific
CLBP subjects with altered body perception and healthy
controls. Therefore, two-point discrimination (TPD),
movement control tests (MCT), as well as the more re-
cent back-photo assessment (BPA) were included.
The first test BPA, which is a visual approach capable
of testing body perception and perceived body image [8].
The alternative visual approach of body image drawing
was dismissed because of its poor performance in a pre-
vious study [11]. BPA uses photographs to reflect a
person’s lower back at modified widths. The subject is
then required to identify the original, unmodified photo-
graph of their back from the various versions. This
method has been used previously only for limbs in pa-
tients with complex regional pain syndrome (CRPS) and
is thought to show changes in the primary sensory cor-
tex S1 representation [8]. However, BPA has not been
validated for CLBP patients. Recent evidence has dem-
onstrated altered body image perception in subjects with
CLBP when assessed by completing a partial drawing of
their back silhouette with the body image drawing ap-
proach. However, the CLBP subjects were unable to
clearly outline their trunk in the painful area [12].
The second test investigates TPD on the lower back,
examining the tactile acuity of LBP patients. Subjects
with LBP have been shown to demonstrate increased
TPD values compared to healthy controls [13, 14]. TPD
has been proposed as a surrogate measure for changes
in the somatosensory cortex (S1) [9, 15–17].
The third test addresses the reduced perception of the
spine [18] displayed by CLBP patients, which affects
movements controlled by the central nervous system
[10, 19]. MCT are common in identifying possible defi-
cits in motor control [20, 21] and can discriminate be-
tween LBP subjects and healthy controls [10, 18–21].
Additionally, movement control impairment (MCI) and
TPD outcomes appear to be associated [17].
The aim of this study was to determine whether BPA,
TPD and MCT, which are thought to reflect sensori-
motor changes, were able to discriminate between sub-
jects with nonspecific CLBP and altered body perception
and healthy controls. This would enable physicians to
detect alterations in the sensorimotor system of nonspe-
cific CLBP subjects using simple clinical tools and, thus,
facilitate the development of tailored management strat-
egies for this challenging LBP subgroup.
Methods
Design
A cross-sectional study was conducted. The study was
approved by the Swiss Ethics Commission of Northwest
and Central Switzerland (EKNZ) (reference number
2015–243). All participants gave their informed written
consent prior to study start and all procedures con-
formed to the Declaration of Helsinki.
Participants
A convenience sample of 60 participants, 30 subjects
with nonspecific CLBP and 30 healthy controls, were re-
cruited from three outpatient physiotherapy clinics in
Central Switzerland. The private clinics were selected ac-
cording to the quantity of patients with relevant cases.
The CLBP and control groups were matched for gender
and age, but no further subgrouping was made.
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Inclusion criteria were: 1) age over 18 years; 2) proficient
in the written and spoken German language; 3) no
current pregnancy, or pregnancy in the past 6 months;
4) at least four points on the Roland Morris Disability
Questionnaire (RMDQ) - indicating at least moderate
disability due to LBP; and 5) the presence of CLBP - de-
fined as at least 3 months of unilateral or bilateral non-
specific LBP. Exclusion criteria were: 1) clinical bedside
signs of nerve root pain, or evidence of specific spinal
pathology (e.g., malignancy, fracture, infection, inflam-
matory joint or bone disease; and 2) surgery on the
lower back in the past 6 months. Healthy controls were
excluded when they had any history of LBP in the past 6
months, or a period of LBP of more than 1 month in the
past.
Questionnaires
Basic demographic data, − gender, age, weight, height,
body mass Index (BMI), affected side, pain duration and
pain intensity - were obtained from all participants. The
Roland Morris Disability Questionnaire (RMDQ) [22,
23] was used to screen for eligibility, with a score of at
least 4 points on this scale being necessary for inclusion.
Subsequently, participants completed the Fear Avoid-
ance Belief Questionnaire (FABQ) [24], Fremantle Back
Awareness Questionnaire (FreBaQ) [23] and Hospital
Anxiety and Depression Scale (HADS) [25–27]. These
questionnaires had been previously validated in the Ger-
man language.
Subjects of the CLBP group were asked additionally to
report the locality of their pain (bilateral, left-sided, or
right-sided), its duration and mean intensity, using a nu-
meric rating scale (NRS). This scale ranges from 0 (no
pain) to 100 (worst pain) [28].
Assessments
Examiners, blinded to the participants’ condition, re-
corded the results of the BPA, TPD and MCT. The
examiner who produced all the back photos made no as-
sessments and was blinded to the subjects’ group. The
two examiners undertaking the physical testing were also
blinded to the subject grouping. The latter were both ex-
perienced physiotherapists with a musculoskeletal
physiotherapy specialisation. However, the tests were
not explicitly trained.
Back-photo assessment
BPA had previously been used to assess limbs in a popu-
lation with complex regional pain syndrome [8]. The
lower back was the focus of this study. The lumbar ver-
tebra four was marked on the skin of the subject and a
photograph was taken from the middle part of the glu-
teal area to the occipital part of the skull to depict the
participant’s back in a standing position. The
photograph was then modified at level L4 in steps of 3%
enlargement and shrinkage, using the GNU Image Ma-
nipulation Program (GIMP 2.8.14 for OS X). We chose
to use 9 different sizes, instead of 7 used by an earlier
study [8] and therefore increased the sizes only by 3%
instead of 5%. The maximal limit was set at ±12%. This
resulted in eight modified photos, plus the original
photo for each participant. The photos were allocated
numbers from 1 to 9 in order of the extent of modifica-
tion. Numbers 1 to 4 were allocated to the shrunken
photos, with 1 representing the photo with the maximal
shrinkage of − 12% (Fig. 1). Number 5 was given to the
original, unmodified photo. Numbers 6 to 9 were allo-
cated to the enlarged photos, with 9 representing the
photo with the maximal enlargement of + 12%. The pho-
tos were arranged on a sheet of paper in a randomised
sequence, with the same sequence being used for all par-
ticipants. The participants were then requested by the
examiner to identify the original photo of their back.
The BPA outcome value was in the range from 0 to 4,
reflecting the number of steps of modification between
the original photo and the photo selected by the subject,
irrespective of direction.
Two-point discrimination
TPD is a reliable intra-rater measure to detect altered
tactile acuity [29]. TPD measurements were taken using
a plastic calliper, according to an established protocol
[15, 17, 30] (Fig. 2). The participant lay prone and un-
able to see the calliper. An examiner measured both the
horizontal and vertical TPD bilaterally on the partici-
pant’s lower back at level L4 [29]. The calliper tip dis-
tance ranged from 100mm to 5mm, with the test
started at the maximum spread. For every correct detec-
tion, the spread distance was decreased by 10 mm. Con-
versely, for every incorrect detection, the spread distance
was increased by 5 mm. This procedure was repeated
three times in descending and ascending order and the
average of the smallest distance between the calliper tips
at which the participant was still able to discriminate be-
tween the two separate points was recorded as the TPD
value [17].
Movement control test
MCI of the lumbar spine was evaluated using a bat-
tery of six tests designed to ascertain the movement
control of the back (Fig. 3). The MCT battery has
been shown to be a reliable tool in detecting im-
paired lumbopelvic control [20, 21, 31]. Before the
assessment start, the examiner explained the six spe-
cific movement tasks of the MCT to the subject.
The following protocol was used for each specific
movement. At the beginning, the subject was ver-
bally instructed by the examiner to perform a
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specific movement. A correctly performed movement
was rated as a negative outcome for this task and
the examiner continued directly to the next specific
movement. When the specific movement was not
performed correctly, the examiner provided verbal
corrections. If the movement was still performed in-
correctly, then the examiner demonstrated the cor-
rect movement. When, with this support, the subject
was able to perform the specific movement correctly,
then the outcome for this task was rated negative
and the examiner went on to verbally instruct the
next specific movement. When the subject was un-
able to perform the specific movement correctly,
even with support, then the outcome for this task
was rated positive and the examiner went on to
Fig. 1 Back-photo assessment (BPA)
Fig. 2 Two point discrimination test (TPD)
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verbally instruct the next specific movement. The
tasks outcomes were recorded and a final score cal-
culated ranging from 0 (all movements performed
correctly) to 6 (no movement performed correctly).
The subjects’ scores were noted as the outcome
values for MCT. A detailed description of the MCT
test battery and the definition of ratings can be
found elsewhere [20].
Statistical analysis
All statistical analyses were performed using R (version
3.2.3) [32]. Normality of data was determined by inspec-
tion of histograms. Demographics, questionnaire data,
BPA, TPD and MCT were analysed with descriptive sta-
tistics. Spearman correlations were used for independent
variables (BPA, TPD, MCT, FreBAQ, FABQ, HADS,
Age, Body height, Body weight, BMI). Multiple logistic
regressions were applied with conditional likelihood to
determine associations between the main outcomes
(BPA, TPD and MCT) with the presence of CLBP. Con-
cerning the goodness-of-fit test criteria for applying a
multiple logistic regression, it was not applicable to run
a Hosmer-Lemesbow test, since this is only suited to un-
conditional logistic regression. The Hosmer-Lemesbow
test is computed with the expected probabilities of an
event. These are unknown for conditional logistic re-
gression because the model omits the unobserved inter-
cept for each individual. As a compromise, a likelihood-
ratio test was added, as well as concordance statistics.
The concordance is defined as the probability that the
prediction goes in the same direction as the actual data.
CI > 0.5 implies a good predictive ability. Checks for out-
liers/influential data and for collinearity were performed.
There was no evidence of outliers/influential data and
there was low collinearity. To check for multicollinearity,
variance inflation factors (VIf) were computed, with cut-
off value 5 [33]. The log odds of the presence of CLBP
were modelled with six covariates. These covariates were
BPA, TPD (left and right horizontal TPD, left and right
vertical TPD) and MCT. The objective was to quantify
the effect of each covariate on the outcome CLBP, re-
ported in odds ratios. The questionnaires revealed no as-
sociations with the main outcomes and were not
investigated further.
Results
Not all data were normally distributed. The conducted
analysis produced the following values for the data set.
Likelihood-ratio test = 6.07 on 6 df, p = 0.4, Concord-
ance = 0.7 (se = 0.118). All VIf were smaller than 4.1,
thus no VIf was more extreme than the cut-off 5.
The demographics of both groups were similar at
baseline, apart from weight and Body Mass Index (BMI),
which were higher in the CLBP group (Table 1). Table 2
contains the results of the assessments. BPA and TPD
values were similar for both groups. Table 3 summarises
Fig. 3 Movement control test batterie of the low back
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the results of the multiple logistic regression analysis.
Significant between-group differences could be demon-
strated for MCT only, with an odds ratio of 1.92 for the
presence of CLBP and a statistically significant 95%CI of
1.00–3.68. This means that for each point greater on the
MCT battery the odds of being a subject with LBP in-
creases 1.92 times. The same result was not found for
TPD or BPA. No statistically significant correlations be-
tween the independent variables were identified
(Table 4). However, the results of the FABQ and FreBaQ
demonstrated large between-group differences (Table




The main objective of this study was to examine the
ability of three commonly performed clinical tests to
discriminate between nonspecific CLBP subjects and
healthy controls.
Our results revealed discriminative ability for the
MCT, but not for the BPA and TPD tests. Consequently,
only the MCT, due to its odds ratio of 1.92 and statisti-
cally significant p-value (0.049) and 95%CI, can be rec-
ommended as a test for the detection of the likelihood
of the presence of LBP. However, the 95%CI lower limit
was near 1 (1.0002–3.677) and close to not being signifi-
cant. It cannot be said whether this difference is clinic-
ally meaningful.
Comparison to earlier studies
This finding for MCT confirms previous results, in
which the ability was found to discriminate between LBP
subjects and healthy controls [10, 18–21]. Luomajoki
et al. cited a mean MCT score of 2.21 (out of 6) for sub-
jects with LBP and 0.75 for healthy controls [21]. In
Table 1 Demographic characteristics
Variables CLBP group (n = 30) Healthy control group (n = 30)
Affected side (bilateral / left / right) 17 / 3 / 10
Gender female / male 15/15 15/15
Variables p-values Mean Range Mean Range
Age (years) 0.40 52.9 (SD 18.0) 25.0–83.0 51.8 (SD 16.5) 22.0–79.0
Weight (kg) 0.01 81.3 (SD 18.0) 50.0–122.0 72.0 (SD 11.9) 52.0–100.0
Body height (cm) 0.38 172.4 (SD 9.7) 157.0–194.0 173.1 (SD 8.7) 155.0–186.0
Body Mass Index < 0.02 27.4 (SD 5.8) 16.9–44.6 24.0 (SD 3.0) 18.3–30.2
Pain duration (months) 131.8 (SD 160) 3.0–660.0
Pain intensity (0–100) 33.4 (SD 20) 4.0–75.0
RMDQ (0–24) 8.2 (SD 4.1) 4.0–21.0 0.07 (SD 0.3) 0.0–1.0
RMDQ Roland Morris Disability Questionnaire
Table 2 Outcomes
Variables CLBP group (n = 30) Healthy control group (n = 30)
BPA wider 18 (60%) 16 (53%)
BPA narrower 8 (26.5%) 10 (33.5%)
BPA original 4 (13.5%) 4 (13.5%)
Variables Median Range Median Range
BPA deviation steps (0–4) 2.0 (IQR 2.0) 0.0–4.0 2.0 (IQR 2.0) 0.0–4.0
TPD horizontal right (mm) 65.0 (IQR 33.8) 15.0–105.0 67.5 (IQR 23.8) 30.0–105.0
TPD horizontal left (mm) 67.5 (IQR 30.0) 30.0–120.0 57.5 (IQR 18.8) 25.0–140.0
TPD vertical right (mm) 45.0 (IQR 20.0) 20.0–110.0 35.0 (IQR 33.8) 15.0–85.0
TPD vertical left (mm) 42.5 (IQR 20.0) 15.0–150.0 35.0 (IQR 28.8) 10.0–90.0
MCT positive (0–6) 3.0 (IQR 2.0) 1.0–5.0 2.0 (IQR 1.0) 0.0–5.0
FABQ (0–96) 33 (IQR 28.8) 0–96 1 (IQR 6.8) 0–37
HADS (0–42) 9 (IQR 5.5) 0–17 3.5 (IQR 5.8) 0–16
FreBaQ (0–36) 7 (IQR 6.8) 0–22 0 (IQR 2.0) 0–8
BPA Back-Photo Assessment, TPD Two-Point Discrimination, MCT Movement Control Tests, FABQ Fear Avoidance Belief Questionnaire, HADS Hospital Anxiety and
Depression Scale, FreBaQ Fremantle Back Awareness Questionnaire
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contrast, both of the groups in this study showed higher
MCT scores: 3.0 for CLBP subjects and 2.0 for healthy
controls. An explanation could be that this current study
included subjects with CLBP only, whereas Luomajoki
et al. also investigated subjects with acute and subacute
LBP [21].
Our results for the BPA test differ from the previous
research by Moseley et al. (2005), in which a similar ap-
proach with CRPS patients was used. Results from this
study demonstrated that the subjects in the chronic pain
group selected photos with a 7% enlargement of the ori-
ginal photo size [8], compared to our study in which
both CLBP subjects and healthy controls tended to
choose enlarged photos of their backs, but with no
meaningful between-group difference. The BPA results
in our study indicate no significant association between
an increased BPA score and a higher chance of suffering
from CLBP. The divergent results might be partly ex-
plained by the different enlargement steps used in the
Moseley et al. study. Our photos were modified in 3%
steps, whereas Moseley et al. used 5% steps. Also in con-
trast to our study, the latter demonstrated a correlation
between the chosen picture and the duration of
symptoms [8]. BPA is a rather novel test for the detec-
tion of altered body perception, based on preliminary
data from CRPS patients, but which has not yet been
validated for CLBP subjects. The focus of this study was
the trunk, whereas Moseley et al. examined limbs. Mose-
ley et al. modified photos of the affected hand, thereby
allowing a comparison of the person’s two hands. In
contrast, modified photos of one area of the back at level
L4 were shown in the current study. Hence, the results
of the two studies cannot be compared directly. Add-
itional research is needed to improve BPA testing. We
recommend that the enlargement steps should be 5% as
used by Moseley et al., and the impact of smaller incre-
ments on significance be investigated.
Our findings for the TPD test also diverge from those
of previous studies. The earlier studies demonstrated the
ability of TPD to discriminate between CLBP subjects
and healthy controls [15, 17, 34]. Luomajoki and Mose-
ley also observed a correlation between TPD and MCT
[17]. In our study, no statistically significant correlation
between the TPD and MCT was identified. Additionally,
no statistically significant correlations among the inde-
pendent variables were found. This accords with
Table 3 Multiple logistic regression
Variables log odds ratio Odds ratio se z-value P-value 95% CI
BPA −0.30 0.74 0.29 −1.03 0.30 0.42–1.31
TPD horizontal right 0.01 1.01 0.02 0.40 0.69 0.96–1.06
TPD horizontal left −0.02 0.98 0.03 −0.56 0.57 0.93–1.04
TPD vertical right 0.03 1.03 0.03 0.92 0.36 0.97–1.10
TPD vertical left 0.01 1.00 0.02 0.08 0.94 0.96–1.05
MCT 0.65 1.92 0.33 1.96 0.05 1.00–3.68
BPA Back-Photo Assessment, TPD Two-Point Discrimination, MCT Movement Control Tests
Table 4 Spearman correlations
Variables TPD h right TPD h left TPD v right TPD v left MCT FreBAQ FABQ HADS Age Body height Body weight BMI BPA
TPD h right –
TPD h left 0.79 –
TPD v right 0.41 0.59 –
TPD v left 0.32 0.58 0.85 –
MCT −0.14 −0.09 −0.09 0.01 –
FreBAQ 0.02 0.09 0.23 0.17 0.22 –
FABQ −0.03 0.08 0.17 0.17 0.23 0.71 –
HADS 0.08 0.11 0.20 0.02 0.06 0.58 0.59 –
Age 0.30 0.38 0.21 0.05 −0.21 −0.16 −0.13 0.20 –
Body height 0.05 0.03 0.04 0.05 0.22 −0.21 −0.12 −0.08 − 0.18 –
Body weight 0.46 0.42 0.12 0.11 0.25 0.10 0.04 0.20 0.17 0.46 –
BMI 0.45 0.44 0.18 0.15 0.14 0.22 0.12 0.27 0.28 −0.03 0.85 –
BPA 0.23 0.26 0.17 0.25 0.09 −0.09 −0.08 0.07 0.15 0.01 0.29 0.35 –
BPA Back-Photo Assessment, TPD Two-Point Discrimination horizontal vertical, MCT Movement Control Tests, FABQ Fear Avoidance Belief Questionnaire, HADS
Hospital Anxiety and Depression Scale, FreBaQ Fremantle Back Awareness Questionnaire, BMI Body Mass Index, h Horizontal, v Vertical
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previous research. Ehrenbrusthoff et al. doubted the
similarity of the underlying construct of the TPD and
the FreBaQ questionnaire and, thus, questioned the cor-
relation between them [35]. However, recent studies
have demonstrated correlations between TPD and body
image drawings, a different visual approach with similar-
ities to BPA [12, 36].
Strengths and limitations
The strength of this study is that it replicates previous
studies using MCT and TPD, but also includes the more
recent BPA assessment. The latter has not been investi-
gated in this population. It addresses the subject of
altered body perception in a chronic pain state when no
specific structural causes in the back can solely explain
the symptoms. This is a field in which further research
is needed.
Our study has some limitations. The investigation of a
specific subgroup of patients with LBP, such as those
with movement control impairment, might have been
more beneficial. Another possible limitation is that the
nonspecific CLBP cohort in this study showed a low
pain intensity of 33.4/100 NRS and disability of 8.2/24 at
baseline. These levels may not have been high enough to
result in significant alterations in the sensorimotor sys-
tem, which could explain the inability of the included
Fig. 5 Box plots of the questionnaires
Fig. 4 Box plots of the main variables
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tests to demonstrate significant discriminative capability.
Nevertheless, it remains unclear as to whether higher
pain intensities and disability levels in a nonspecific
CLBP cohort, through the detection of potentially larger
alterations in the sensorimotor system, would have re-
sulted in greater discriminative ability of the tests. Previ-
ous research has shown a change in proprioception due
to exercise and, therefore, in movement control [1, 37,
38]. Therefore, whether the activity level CLBP subjects
has an impact on outcomes needs to be investigated. It
is unclear whether CLBP subjects with higher activity
levels would have different outcomes to those with lower
activity levels.
A methodological limitation of this study is that two
different examiners performed the TPD assessments to
maintain assessor blinding. Catley et al. (2013) ques-
tioned the inter-rater reliability of TPD on the lower
back [29]. The raters in this study did not explicitly train
the methodology of the measurements with each other
and this could have influenced the results.
Neither selection bias can be negated as the patients
were by sample of convenience and from only three
practises. It might have been also wise to subgroup pa-
tients according to system introduced by O’Sullivan [2].
It is also unclear whether the difference in MCT out-
comes between the study groups should be viewed as
clinically important, since the levels of minimal clinically
meaningful differences have yet to be reported. The
raters also did not explicitly train with each other for the
MCT prior to the testing. However, both raters were ed-
ucated to at least master level in musculoskeletal physio-
therapy and were experienced in MCT testing.
Conclusion
The ability of BPA, TPD and MCT to discriminate al-
tered body perception in nonspecific CLBP subjects was
investigated. A strength of this study is its focus on al-
tered body perception of the back in a chronic pain
state, where no specific structural causes could solely ex-
plain the symptoms. This is a field in which further re-
search is necessary.
Only the MCT was shown to be able to in discrim-
inate between nonspecific CLBP subjects (with low to
moderate pain and disability levels) and healthy con-
trols. Therefore, MCT can be recommended as a sim-
ple clinical tool to detect alterations in the
sensorimotor system of nonspecific CLBP subjects
and, hence, to facilitate the development of tailored
management strategies for this challenging LBP sub-
group. However, further research is required to eluci-
date the potential of other simple clinical tests, such
as BPA and TPD, to detect alterations in the sensori-
motor system in CLBP subjects.
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